Madeline currently serves as Associate Director of Clinical Operations. She is an experienced clinical research specialist with 10 years of experience working on clinical trials in Immunology, Neuroscience, and Oncology across Phase I and II studies. Extensive experience with regulatory interactions, site and vendor management, and project coordination. She has independently managed various activities associated with multiple clinical trials in accordance with designated project assignments, including leading a global phase 2 trial in Alzheimer’s Disease. Currently leading clinical operations for NEULARK Phase II study in Parkinson’s disease. She previously had roles of increasing responsibility at Alector, Nurix, and Covance. Madeline obtained a MbA from Indiana University and a BS degree in Electrical Engineering from Vanderbilt.
Associated Grants
-
Expansion of the NEULARK Study, Examining the Effects of NEU-411 on LRRK2-driven Parkinson’s Patients, Into Israel
2026